These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 3244385)
1. Stenosis and vascular damage as a cause of thrombosis in the dog femoral artery. Prosdocimi M; Zatta A; Finesso M Naunyn Schmiedebergs Arch Pharmacol; 1988 Oct; 338(4):430-7. PubMed ID: 3244385 [TBL] [Abstract][Full Text] [Related]
2. Combined ADP and thromboxane A2 antagonism prevents cyclic flow variations in stenosed and endothelium-injured arteries in nonhuman primates. Yao SK; McNatt J; Cui K; Anderson HV; Maffrand JP; Buja LM; Willerson JT Circulation; 1993 Dec; 88(6):2888-93. PubMed ID: 8252702 [TBL] [Abstract][Full Text] [Related]
7. Effects of the selective thromboxane synthetase inhibitor dazoxiben on variations in cyclic blood flow in stenosed canine coronary arteries. Bush LR; Campbell WB; Buja LM; Tilton GD; Willerson JT Circulation; 1984 Jun; 69(6):1161-70. PubMed ID: 6546902 [TBL] [Abstract][Full Text] [Related]
8. The effects of alpha 2-adrenergic and serotonergic receptor antagonists on cyclic blood flow alterations in stenosed canine coronary arteries. Bush LR; Campbell WB; Kern K; Tilton GD; Apprill P; Ashton J; Schmitz J; Buja LM; Willerson JT Circ Res; 1984 Nov; 55(5):642-52. PubMed ID: 6488486 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of thromboxane A2 synthase inhibition, singly or combined with thromboxane A2/prostaglandin endoperoxide receptor antagonism, on occlusive thrombosis elicited by endothelial cell injury or by deep vascular damage in canine coronary arteries. Vandeplassche G; Hemans C; Van de Water A; Xhonneux R; Wouters L; Van Ammel K; De Clerck F Circ Res; 1991 Aug; 69(2):313-24. PubMed ID: 1830517 [TBL] [Abstract][Full Text] [Related]
10. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Yao SK; Ober JC; Krishnaswami A; Ferguson JJ; Anderson HV; Golino P; Buja LM; Willerson JT Circulation; 1992 Oct; 86(4):1302-9. PubMed ID: 1394936 [TBL] [Abstract][Full Text] [Related]
11. Reduction in the incidence of thrombosis by the thromboxane synthetase inhibitor CGS 13080 in a canine model of coronary artery injury. Simpson PJ; Smith CB; Rosenthal G; Lucchesi BR J Pharmacol Exp Ther; 1986 Aug; 238(2):497-501. PubMed ID: 3735129 [TBL] [Abstract][Full Text] [Related]
12. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs. Hsieh CP; Sakai K; Bruns GC; Dage RC J Cardiovasc Pharmacol; 1994 Nov; 24(5):761-72. PubMed ID: 7532754 [TBL] [Abstract][Full Text] [Related]
13. Serotonin-induced vasoconstriction in the perfused canine femoral artery can be blocked in vivo by ketanserin. Meschig R; Breuer J; Arnold G J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S56-9. PubMed ID: 2412060 [TBL] [Abstract][Full Text] [Related]
14. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis. Folts J Circulation; 1991 Jun; 83(6 Suppl):IV3-14. PubMed ID: 2040070 [TBL] [Abstract][Full Text] [Related]
15. A comparative evaluation of thromboxane receptor blockade, thromboxane synthase inhibition and both in animal models of arterial thrombosis. Salvati P; Dho L; Ukmar G; Vaga L; Rimoldi O; Patrono C J Pharmacol Exp Ther; 1994 Apr; 269(1):238-45. PubMed ID: 8169831 [TBL] [Abstract][Full Text] [Related]
16. Vascular prostaglandin and thromboxane production in a canine model of myocardial ischemia. Schmitz JM; Apprill PG; Buja LM; Willerson JT; Campbell WB Circ Res; 1985 Aug; 57(2):223-31. PubMed ID: 3926340 [TBL] [Abstract][Full Text] [Related]
17. Combined thromboxane A2 synthetase inhibition and receptor blockade are effective in preventing spontaneous and epinephrine-induced canine coronary cyclic flow variations. Yao SK; Rosolowsky M; Anderson HV; Golino P; NcNatt JM; De Clerck F; Buja LM; Willerson JT J Am Coll Cardiol; 1990 Sep; 16(3):705-13. PubMed ID: 2143767 [TBL] [Abstract][Full Text] [Related]
18. Effect of thromboxane and serotonin receptor antagonists on intracoronary platelet deposition in dogs with experimentally stenosed coronary arteries. Golino P; Buja LM; Ashton JH; Kulkarni P; Taylor A; Willerson JT Circulation; 1988 Sep; 78(3):701-11. PubMed ID: 3409505 [TBL] [Abstract][Full Text] [Related]
19. ADP plays an important role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-injured canine coronary arteries. Yao SK; Ober JC; McNatt J; Benedict CR; Rosolowsky M; Anderson HV; Cui K; Maffrand JP; Campbell WB; Buja LM Circ Res; 1992 Jan; 70(1):39-48. PubMed ID: 1727687 [TBL] [Abstract][Full Text] [Related]
20. Femoral artery flow in deep vein thrombosis: hemodynamics of slow versus acute femoral vein occlusion. Shifrin EG Angiology; 1985 Mar; 36(3):154-9. PubMed ID: 4025927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]